As of 2025-07-04, the Intrinsic Value of Cantel Medical Corp (CMD) is 15.27 USD. This CMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 80.37 USD, the upside of Cantel Medical Corp is -81.00%.
The range of the Intrinsic Value is 6.16 - 38.16 USD
Based on its market price of 80.37 USD and our intrinsic valuation, Cantel Medical Corp (CMD) is overvalued by 81.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 6.16 - 38.16 | 15.27 | -81.0% |
| DCF (Growth 10y) | 16.55 - 59.89 | 28.97 | -64.0% |
| DCF (EBITDA 5y) | 18.93 - 32.86 | 23.66 | -70.6% |
| DCF (EBITDA 10y) | 28.48 - 48.75 | 35.71 | -55.6% |
| Fair Value | 6.89 - 6.89 | 6.89 | -91.43% |
| P/E | 6.23 - 54.34 | 28.46 | -64.6% |
| EV/EBITDA | 19.11 - 52.58 | 34.56 | -57.0% |
| EPV | 8.05 - 15.30 | 11.67 | -85.5% |
| DDM - Stable | 7.52 - 21.05 | 14.28 | -82.2% |
| DDM - Multi | 10.59 - 23.20 | 14.56 | -81.9% |
| Market Cap (mil) | 3,400.79 |
| Beta | 1.55 |
| Outstanding shares (mil) | 42.31 |
| Enterprise Value (mil) | 4,101.30 |
| Market risk premium | 4.24% |
| Cost of Equity | 8.76% |
| Cost of Debt | 5.67% |
| WACC | 7.58% |